● Recruiting

A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease

Condition: Renal Impairment · Sponsor: Incyte Corporation

PhasePhase 1

Planned participants16

Who can joinAll sexes, 18 Years to 85 Years

Healthy volunteersNo

About this study

This study will be conducted to assess the safety and pharmacokinetics of INCB123667 when administered orally to adult participants with severe renal impairment or end stage renal disease.

This description comes directly from the study's public registry record.

Talk to the study team

Incyte Corporation Call Center (US) · 1.855.463.3463 · medinfo@incyte.com

Incyte Corporation Call Center (ex-US) · +800 00027423 · eumedinfo@incyte.com

Always discuss trial participation with your own doctor first.

Locations (2)

Floridian Clinical Research	Miami Lakes, Florida, United States	Recruiting
Orlando Clinical Research Center	Orlando, Florida, United States	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07559396